Don’t use Molnupiravir for treating COVID-19 in younger population, warns Dr NK Arora, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

“Molnupiravir benefits when given at an early stage of the infection. It reduces the possibility of hospitalisation and ICU admissions. Irrational use is dangerous. It will contribute in the treatment of senior citizens, particularly those with comorbidities and if given at an early stage, it will reduce the chances of severe disease,” Dr Arora said., “Molnupiravir benefits when given at an early stage of the infection. It reduces the possibility of hospitalisation and ICU admissions. Irrational use is dangerous. It will contribute in the treatment of senior citizens, particularly those with comorbidities and if given at an early stage, it will reduce the chances of severe disease,” Dr Arora said., , Read More